PL2352032T3 - Sposób usuwania przeciwciał przeciwko receptorowi endoteliny z próbek krwi - Google Patents

Sposób usuwania przeciwciał przeciwko receptorowi endoteliny z próbek krwi

Info

Publication number
PL2352032T3
PL2352032T3 PL10191894T PL10191894T PL2352032T3 PL 2352032 T3 PL2352032 T3 PL 2352032T3 PL 10191894 T PL10191894 T PL 10191894T PL 10191894 T PL10191894 T PL 10191894T PL 2352032 T3 PL2352032 T3 PL 2352032T3
Authority
PL
Poland
Prior art keywords
endothelin
blood samples
receptor antibodies
removing anti
antibodies
Prior art date
Application number
PL10191894T
Other languages
English (en)
Inventor
Harald Heidecke
Kai Schulze-Forster
Original Assignee
Celltrend Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celltrend Gmbh filed Critical Celltrend Gmbh
Publication of PL2352032T3 publication Critical patent/PL2352032T3/pl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/5754—Endothelin, vasoactive intestinal contractor [VIC]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/102—Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/104—Lupus erythematosus [SLE]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders
    • G01N2800/245—Transplantation related diseases, e.g. graft versus host disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/321—Arterial hypertension
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/328—Vasculitis, i.e. inflammation of blood vessels

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL10191894T 2006-08-04 2007-07-31 Sposób usuwania przeciwciał przeciwko receptorowi endoteliny z próbek krwi PL2352032T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06016297A EP1884776A1 (en) 2006-08-04 2006-08-04 Method for diagnosis of a disease involving an anti-endothelin-receptor antibody
EP10191894.4A EP2352032B1 (en) 2006-08-04 2007-07-31 Method for removing anti-endothelin-receptor antibodies from blood samples
EP07802441A EP2057470B1 (en) 2006-08-04 2007-07-31 Method for diagnosis of a disease involving an anti-endothelin-receptor antibody

Publications (1)

Publication Number Publication Date
PL2352032T3 true PL2352032T3 (pl) 2015-10-30

Family

ID=37622227

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10191894T PL2352032T3 (pl) 2006-08-04 2007-07-31 Sposób usuwania przeciwciał przeciwko receptorowi endoteliny z próbek krwi

Country Status (5)

Country Link
US (1) US8592164B2 (pl)
EP (3) EP1884776A1 (pl)
ES (2) ES2388082T3 (pl)
PL (1) PL2352032T3 (pl)
WO (1) WO2008015219A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1884776A1 (en) 2006-08-04 2008-02-06 Celltrend GmbH Method for diagnosis of a disease involving an anti-endothelin-receptor antibody
ES2336350T3 (es) 2006-08-04 2010-04-12 Celltrend Gmbh Procedimiento para el diagnostico de una enfermedad que implica un anticuerpo antirreceptor at1.
RU2366365C1 (ru) * 2008-05-15 2009-09-10 Людмила Николаевна Елисеева Способ дифференцированной оценки тяжести синдрома рейно при системной склеродермии
CN103728454B (zh) * 2012-10-10 2016-05-18 吴庄民 基于表位抗原肽的抗内皮素受体a抗体酶联免疫试剂盒及其应用
ES2845656T3 (es) * 2014-09-18 2021-07-27 Immucor Gti Diagnostics Inc Kits y procedimientos para detectar anticuerpos anticélulas endoteliales en rechazo de aloinjertos
US20170082619A1 (en) 2015-09-23 2017-03-23 One Lambda, Inc. Methods of Detecting Alloantibodies Using HLA and Non-HLA Antigens
WO2017075380A1 (en) * 2015-10-30 2017-05-04 The Johns Hopkins University Angiotensin receptor autoantibodies as biomarker for effective usage of angiotensin receptor blockers
CN109374902A (zh) * 2018-10-08 2019-02-22 杭州康知生物科技有限公司 一种定量检测IgG4的乳胶增强免疫比浊试剂盒及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2866182B2 (ja) * 1990-10-08 1999-03-08 日本ケミファ株式会社 エンドセリン受容体
FR2787330A1 (fr) 1998-12-18 2000-06-23 Sanofi Sa Composition pharmaceutique contenant, en association, un antagoniste des recepteurs at1 de l'angiotensine ii et un immunosuppresseur pour la prevention ou le traitement des complications vasculaires du rejet de greffe
DE19954305A1 (de) 1998-12-24 2000-06-29 Max Delbrueck Centrum Peptide des AT¶1¶-Rezeptors und ihre Verwendung, insbesondere für die Diagnostider Präeklampsie
JP2002539075A (ja) 1998-12-24 2002-11-19 マックス−デルブルック−セントラム フュール モレクラーレ メディツィン At1受容体のペプチド、及び子癇前症、悪性高血圧症におけるその使用
CA2314811A1 (en) 2000-08-02 2002-02-02 Brian Archibald Macvicar Autoimmunity to angiotensin at1 receptors in schizophrenia
DE10123929A1 (de) 2001-05-11 2002-11-21 Celltrend Gmbh Verfahren zur Vorhersage eines Transplantatabstoßungsrisikos und immunologischer Testkit
WO2004051280A2 (de) * 2002-11-29 2004-06-17 Max-Delbrück-Centrum für Molekulare Medizin Bestimmung agonistischer autoantikörper
WO2006060336A2 (en) * 2004-11-30 2006-06-08 The Johns Hopkins University Endothelin-2 and retinal damage
EP1884776A1 (en) 2006-08-04 2008-02-06 Celltrend GmbH Method for diagnosis of a disease involving an anti-endothelin-receptor antibody
ES2336350T3 (es) 2006-08-04 2010-04-12 Celltrend Gmbh Procedimiento para el diagnostico de una enfermedad que implica un anticuerpo antirreceptor at1.

Also Published As

Publication number Publication date
EP2352032A1 (en) 2011-08-03
ES2540801T3 (es) 2015-07-13
US8592164B2 (en) 2013-11-26
EP2057470B1 (en) 2012-07-11
US20100075348A1 (en) 2010-03-25
EP2352032B1 (en) 2015-04-15
WO2008015219A1 (en) 2008-02-07
EP2057470A1 (en) 2009-05-13
ES2388082T3 (es) 2012-10-08
EP1884776A1 (en) 2008-02-06

Similar Documents

Publication Publication Date Title
GB2437519B (en) Method for separation
GB2450434B (en) Method for sampling formation fluids
EP2024742A4 (en) SYSTEM AND METHOD FOR PREPARING SAMPLES
GB0813052D0 (en) System and method for obtaining well fluid samples
EP2061812A4 (en) METHOD FOR THE PRODUCTION OF ANTIBODIES
IL199360A0 (en) Method for extracting a protein from milk
EP2077757A4 (en) MEANS FOR SAMPLING ANIMAL BLOOD
PL2215031T3 (pl) Sposób przetwarzania pucolanów
PL2027158T3 (pl) Sposób immunizacji gatunków ptaków
ZA200704159B (en) Method for analysis of pellet-cladding interaction
IL202889A0 (en) Methods for isolating long fragment rna from fixed samples
IL204949A0 (en) Method for purifying an fc- containing protein
PL1866651T3 (pl) Sposób analizy próbek krwi
GB2453293B (en) System and method for optical analysis
SI2020845T1 (sl) Metoda za seäśnjo
IL184417A0 (en) Method for analyzing oligosaccharides from blood plasma
PL1785730T3 (pl) Układ i sposób badania próbki ciekłej
PL2249164T3 (pl) Sposób przetwarzania płynu biologicznego do oznaczania analitu
TWI318684B (en) Method for imaging a sample and system thereof
PL2650302T3 (pl) Sposób usuwania endotoksyny z białek
GB0503244D0 (en) Method for separation
IL196198A0 (en) A method of modifying a macromolecule without prior extraction from a sample
GB0624462D0 (en) Method for determining gentoxicity
PL1918709T3 (pl) Sposób analizowania płytek krwi
DE602005019704D1 (de) Verfahren zur chromatographischen trennung